FDA greenlights AI software that detects fractures and traumatic injuries

New artificial intelligence (AI) software that helps providers diagnose fractures and traumatic injuries on radiographs has been given the green light by the U.S. Food and Drug Administration (FDA). 

Gleamer, a French company that specializes in the development of AI software in the radiology space, announced the FDA clearance of its BoneView AI software in a press release earlier this week. 

“In the value-based U.S. health care system, providers tell us they want to improve the radiographic diagnostic process, which accounts for a huge part of their workload, and optimize patient…